33450997|t|Mitophagy Modulation, a New Player in the Race against ALS.
33450997|a|Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disease that usually results in respiratory paralysis in an interval of 2 to 4 years. ALS shows a multifactorial pathogenesis with an unknown etiology, and currently lacks an effective treatment. The vast majority of patients exhibit protein aggregation and a dysfunctional mitochondrial accumulation in their motoneurons. As a result, autophagy and mitophagy modulators may be interesting drug candidates that mitigate key pathological hallmarks of the disease. This work reviews the most relevant evidence that correlate mitophagy defects and ALS, and discusses the possibility of considering mitophagy as an interesting target in the search for an effective treatment for ALS.
33450997	55	58	ALS	Disease	MESH:D000690
33450997	60	89	Amyotrophic lateral sclerosis	Disease	MESH:D000690
33450997	91	94	ALS	Disease	MESH:D000690
33450997	108	133	neurodegenerative disease	Disease	MESH:D019636
33450997	158	179	respiratory paralysis	Disease	MESH:D012133
33450997	212	215	ALS	Disease	MESH:D000690
33450997	343	351	patients	Species	9606
33450997	671	674	ALS	Disease	MESH:D000690
33450997	801	804	ALS	Disease	MESH:D000690

